drugset / Trial / NCT05377554
Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery
RandomizedParallel-groupSingle-blindTreatment
Summary
This protocol describes prospective, open-label, blinded, randomized controlled, multicenter pivotal studies to evaluate bevonescein.
Timeline
- Start
- 2022-04-29
- Primary completion
- 2025-10-27
- Completion
- 2025-11-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevonescein | Peptide | — | — |
Indications
No indication recorded.